Stem Cell Stocks 5/3/09: The Week That Was

As expected, the stem cell stocks still did not move this week. A couple of stocks with connections to cancer or the flu moved early in the week, but gave up their gains. Look for there to be continued sporadic movement in the sector.

Top Stem Cell Stock Performer(s) for Last Week:

- Cryo-Cell International (CCEL) = Up 54% for the week; This stock stock has more than doubled in the last 2 1/2 weeks. The rise is began shortly after an earnings report that pointed to a bright future. Look for a pull back shortly.

Worst Stem Cell Stock Performer(s) for Last Week:

- Stem Cell Therapy Intl (SCII) = Down -21% for the week on average volume; No significant news; not out of the ordinary for a penny stock

Stem Cell Stocks Current Price and % Up or Down 4/27/09 - 5/01/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.49; Down -2%
Aastrom Biosciences (ASTM) = Cur Price: $0.38; Up 17%
BioTime, Inc. (BTIM) = Cur Price: $1.94; Down -11%
Celgene Corp (CELG) = Cur Price: $39.54; Down -1%
Cytori Therapeutics (CYTX) = Cur Price: $1.82; Up 2%
Geron Corp (GERN) = Cur Price: $5.10; Up 3%
ThermoGenesis (KOOL) = Cur Price: $0.67; Up 14%
Osiris Therapeutics (OSIR) = Cur Price: $12.42; Up 1%
StemCell Inc. (STEM) = Cur Price: $1.66; Up 2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.099; Down -1%
Athersys Inc. (ATHX) = Cur Price: $0.81; Up 1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.074; Down -8%
Bioheart Inc. (BHRT) = Cur Price: $0.78; Up 13%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0054; Down -2%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.23; Up 54%
Neuralstem (CUR) = Cur Price: $1.15; Down -3%
International Stem Cell (ISCO.OB) = Cur Price: $0.47; Down -10%
MultiCell Technologies (MCET.OB) = Cur Price: $0.011; Up 10%
Pluristem Therapeutics (PSTI) = Cur Price: $1.52; Up 14%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.075; Down -21%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.039; Down -5%

Catalyst(s) for the Week:

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.